Use of Biological Agents in Asthma: Pharmacoeconomic Lessons Learned From Omalizumab.
Division of Allergy and Immunology, New Jersey Medical School, Newark, NJ.
Steven
S
Draikiwicz
Division of Allergy and Immunology, New Jersey Medical School, Newark, NJ. Electronic address: nallopp@optonline.net.
John
J
Oppenheimer
D018927:Anti-Asthmatic Agents / Q000191:economics* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D000069444:Omalizumab / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
D018927:Anti-Asthmatic Agents; D000069444:Omalizumab